Induction of heparin-binding epidermal growth factor-like growth factor mRNA by protein kinase C activators. 1994

M S Tan, and J C Tsai, and Y J Lee, and H C Chen, and S J Shin, and Y H Lai, and M A Perrella, and C Bianchi, and S Higashiyama, and W Endege
Department of Biology, Kaohsiung Medical College, Taiwan, Republic of China.

Heparin-binding epidermal growth factor-like growth factor (HB-EGF) is a potent smooth muscle cell mitogen of macrophage origin. To determine whether the HB-EGF gene is transcribed and regulated in mesangial cells, we measured HB-EGF mRNA levels in cultured rat mesangial cells by RNA blot analysis. A 2.5-kb HB-EGF mRNA was detected in unstimulated mesangial cells. The protein kinase C activator 12-O-tetradecanoylphorbol 13-acetate (TPA) increased HB-EGF mRNA levels by 15-fold in mesangial cells, and this induction of HB-EGF mRNA by TPA was both time- and dose-dependent. HB-EGF mRNA could also be stimulated by 10% fetal calf serum, ionomycin, thrombin, and endothelin-1. Staurosporine, a protein kinase C inhibitor, abolished the induction of HB-EGF mRNA by TPA and serum. To determine whether HB-EGF is mitogenic for mesangial cells, we transfected COS cells with HB-EGF expression plasmids. Culture medium from COS cells transfected with these plasmids increased 3H-thymidine incorporation in mesangial cells in a dose-dependent manner. To our knowledge, this is the first report that HB-EGF is expressed in renal cells. This inducible transcription of HB-EGF suggests that it may have an autocrine role in mesangial cell proliferation in kidney disease.

UI MeSH Term Description Entries
D008297 Male Males
D011493 Protein Kinase C An serine-threonine protein kinase that requires the presence of physiological concentrations of CALCIUM and membrane PHOSPHOLIPIDS. The additional presence of DIACYLGLYCEROLS markedly increases its sensitivity to both calcium and phospholipids. The sensitivity of the enzyme can also be increased by PHORBOL ESTERS and it is believed that protein kinase C is the receptor protein of tumor-promoting phorbol esters. Calcium Phospholipid-Dependent Protein Kinase,Calcium-Activated Phospholipid-Dependent Kinase,PKC Serine-Threonine Kinase,Phospholipid-Sensitive Calcium-Dependent Protein Kinase,Protein Kinase M,Calcium Activated Phospholipid Dependent Kinase,Calcium Phospholipid Dependent Protein Kinase,PKC Serine Threonine Kinase,Phospholipid Sensitive Calcium Dependent Protein Kinase,Phospholipid-Dependent Kinase, Calcium-Activated,Serine-Threonine Kinase, PKC
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D004247 DNA A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine). DNA, Double-Stranded,Deoxyribonucleic Acid,ds-DNA,DNA, Double Stranded,Double-Stranded DNA,ds DNA
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004789 Enzyme Activation Conversion of an inactive form of an enzyme to one possessing metabolic activity. It includes 1, activation by ions (activators); 2, activation by cofactors (coenzymes); and 3, conversion of an enzyme precursor (proenzyme or zymogen) to an active enzyme. Activation, Enzyme,Activations, Enzyme,Enzyme Activations
D004815 Epidermal Growth Factor A 6-kDa polypeptide growth factor initially discovered in mouse submaxillary glands. Human epidermal growth factor was originally isolated from urine based on its ability to inhibit gastric secretion and called urogastrone. Epidermal growth factor exerts a wide variety of biological effects including the promotion of proliferation and differentiation of mesenchymal and EPITHELIAL CELLS. It is synthesized as a transmembrane protein which can be cleaved to release a soluble active form. EGF,Epidermal Growth Factor-Urogastrone,Urogastrone,Human Urinary Gastric Inhibitor,beta-Urogastrone,Growth Factor, Epidermal,Growth Factor-Urogastrone, Epidermal,beta Urogastrone
D005786 Gene Expression Regulation Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control (induction or repression) of gene action at the level of transcription or translation. Gene Action Regulation,Regulation of Gene Expression,Expression Regulation, Gene,Regulation, Gene Action,Regulation, Gene Expression
D005920 Glomerular Mesangium The thin membranous structure supporting the adjoining glomerular capillaries. It is composed of GLOMERULAR MESANGIAL CELLS and their EXTRACELLULAR MATRIX. Mesangium, Glomerular,Mesangial Extracellular Matrix,Extracellular Matrices, Mesangial,Extracellular Matrix, Mesangial,Glomerular Mesangiums,Matrices, Mesangial Extracellular,Matrix, Mesangial Extracellular,Mesangial Extracellular Matrices,Mesangiums, Glomerular

Related Publications

M S Tan, and J C Tsai, and Y J Lee, and H C Chen, and S J Shin, and Y H Lai, and M A Perrella, and C Bianchi, and S Higashiyama, and W Endege
August 1995, The Journal of clinical investigation,
M S Tan, and J C Tsai, and Y J Lee, and H C Chen, and S J Shin, and Y H Lai, and M A Perrella, and C Bianchi, and S Higashiyama, and W Endege
May 2001, Journal of the American Society of Nephrology : JASN,
M S Tan, and J C Tsai, and Y J Lee, and H C Chen, and S J Shin, and Y H Lai, and M A Perrella, and C Bianchi, and S Higashiyama, and W Endege
August 1996, Neuroscience letters,
M S Tan, and J C Tsai, and Y J Lee, and H C Chen, and S J Shin, and Y H Lai, and M A Perrella, and C Bianchi, and S Higashiyama, and W Endege
December 1992, The Journal of biological chemistry,
M S Tan, and J C Tsai, and Y J Lee, and H C Chen, and S J Shin, and Y H Lai, and M A Perrella, and C Bianchi, and S Higashiyama, and W Endege
July 2020, Reproduction (Cambridge, England),
M S Tan, and J C Tsai, and Y J Lee, and H C Chen, and S J Shin, and Y H Lai, and M A Perrella, and C Bianchi, and S Higashiyama, and W Endege
June 1997, Journal of molecular and cellular cardiology,
M S Tan, and J C Tsai, and Y J Lee, and H C Chen, and S J Shin, and Y H Lai, and M A Perrella, and C Bianchi, and S Higashiyama, and W Endege
September 2000, The Journal of laboratory and clinical medicine,
M S Tan, and J C Tsai, and Y J Lee, and H C Chen, and S J Shin, and Y H Lai, and M A Perrella, and C Bianchi, and S Higashiyama, and W Endege
February 1994, Proceedings of the National Academy of Sciences of the United States of America,
M S Tan, and J C Tsai, and Y J Lee, and H C Chen, and S J Shin, and Y H Lai, and M A Perrella, and C Bianchi, and S Higashiyama, and W Endege
June 1997, Biochemical and biophysical research communications,
M S Tan, and J C Tsai, and Y J Lee, and H C Chen, and S J Shin, and Y H Lai, and M A Perrella, and C Bianchi, and S Higashiyama, and W Endege
May 2017, FASEB journal : official publication of the Federation of American Societies for Experimental Biology,
Copied contents to your clipboard!